Update in Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study

Laboratoire d'Immunologie, CHU de la Conception, 147, Bd Baille, Marseille 13005, France.
World Journal of Gastroenterology (Impact Factor: 2.43). 05/2007; 13(16):2312-8.
Source: PubMed

ABSTRACT Anti-Saccharomyces cerevisiae antibodies (ASCA), anti-nuclear associated anti-neutrophil antibodies (NANA) and antibodies to exocrine pancreas (PAB), are serological tools for discriminating Crohn's disease (CrD) and ulcerative colitis (UC). Like CrD, coeliac disease (CoD) is an inflammatory bowel disease (IBD) associated with (auto) antibodies. Performing a multicenter study we primarily aimed to determine the performance of ASCA, NANA and PAB tests for IBD diagnosis in children and adults, and secondarily to evaluate the prevalence of these markers in CoD.
Sera of 109 patients with CrD, 78 with UC, 45 with CoD and 50 healthy blood donors were retrospectively included. ASCA, NANA and PAB were detected by indirect immunofluorescence (IIF).
ASCA+/NANA- profile displayed a positive predictive value of 94.2% for CrD. Detection of ASCA was correlated with a more severe clinical profile of CrD and treatment of the disease did not influence their serum levels. ASCA positivity was found in 37.9% of active CoD. PAB were found in 36.7% CrD and 13.3% CoD patients and were not correlated with clinical features of CrD, except with an early onset of the disease. Fifteen CrD patients were ASCA negative and PAB positive.
ASCA and PAB detected by IIF are specific markers for CrD although their presence does not rule out a possible active CoD. The combination of ASCA, NANA and PAB tests improves the sensitivity of immunological markers for CrD. Repeating ASCA, NANA, and PAB testing during the course of CrD has no clinical value.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Recently, researches using virtual space effectively are drawing attention. We proposed a model to connect real and virtual by constructing an elaborate virtual space. We also experimented the awareness of users by avatars. In this paper, we focus on modeling of dynamic behavior of avatars that appear to give awareness of users in the virtual collaborative space. We employ cell modeling to represent virtual 3D world, and avatars to represent their behavior using local neighbor rules. Owing to this approach, we embed geometry of virtual 3D world as well as physical factors as natural environment to provide real time simulation field.
    Communications, Computers and signal Processing, 2003. PACRIM. 2003 IEEE Pacific Rim Conference on; 09/2003
  • [Show abstract] [Hide abstract]
    ABSTRACT: Crohn's disease (CD) is a complex and heterogeneous inflammatory disorder that is part of inflammatory bowel diseases. Its diagnosis is performed on clinical presentation and results of radiography, endoscopy and histological findings. New noninvasive diagnostic biomarkers are needed to allow rapid and accurate CD discrimination. Blood-derived biomarkers correlating with disease activity, supported by genetic evidences and valid for all CD patients subtypes are still missing. Hence, no biomarkers and no related diagnostic tests are recommended or used alone for CD diagnosis in clinical practice. This review describes diagnosis tests based on the detection/quantification of specific acute-phase reactant proteins, enzymes and derived antibody response developed by inflammatory bowel disease patients for pathogens or symbiotic flora determinant, as well as autoantibodies. Their power as diagnostic tools is discussed, as well as new high-throughput techniques, such as microarrays and proteomics, for the discovery of new CD clinical biomarkers and for the development of specific CD diagnostic tests. Some rapidly evolving nanotechnologies, mathematical analysis and bioinformatics methods are also mentioned to highlight their importance for further accurate CD diagnosis.
    Expert Review of Molecular Diagnostics 06/2008; 8(3):327-37. DOI:10.1586/14737159.8.3.327 · 4.27 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Les marqueurs de référence de dépistage des MICI restent à ce jour les anticorps anti-Saccharomyces cerevisiae (ASCA) et les ANCA atypiques de type NANA. Leur intérêt réside également dans leur valeur prédictive dans les colites indéterminées, dans leur valeur pronostique au cours des MICI et plus récemment dans leur association à des phénotypes particuliers, notamment dans la maladie de Crohn. Cet article fait également le point sur la place des autres marqueurs des MICI dont les anticorps antipancréas exocrine et des marqueurs plus récents comme les anticorps anti-antigènes microbiens (antiporine OmpC de l’Escherichia coli, antiséquence I2 du Pseudomonas fluorescens, antiprotéine CBir1 dérivée de la flagelline, anti-OmpW du Bacteroides caccae, anti-MAP pour Mycobacterium avium subspecies paratuberculosis) et les anticorps antiglycans (antimannobioside, antilaminaribioside et antichitobioside).
    Immuno-analyse & Biologie Spécialisée 08/2008; 23(4):202-211. DOI:10.1016/j.immbio.2008.07.007 · 0.11 Impact Factor
Show more


Available from